Webinar Overview

The rise of next generation biologics comes with a need for more advanced characterization methods. Protein-based gene therapies, such as adeno-associated viruses (AAV), rely on mass spectrometry analysis to ensure their post-translational modifications (PTMs) are in place after production.

In the third installment of our four-part webinar series, see how utilizing a modern mass spectrometer can determine amino acid sequences and sequential fragmentation more quickly, and why it’s important to the development and release of biopharmaceuticals.

 

Webinar Presenter

Yan Zhi Headshot

Andrew Hanneman
Scientific Advisor, Mass Spectrometry Laboratory
Charles River

 

View the other webinars in this series:

 

We are providing digital education options to keep you learning about topics you may be interested in. For more information, visit criver.com/digital-education.